Latest & greatest articles for obesity

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on obesity or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on obesity and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for obesity

161. Which service or policy mechanisms, models or approaches, have been shown to be effective or ineffective at reducing the inequalities that are known to have an impact on childhood obesity?

), and examined if studies targeting high risk groups or individuals were more successful in relation to preventing overweight and obesity than studies targeting general population groups (9). Among 15 identified studies, 7 targeted children or adolescents susceptible to future overweight or obesity. Intervention studies that did not target high-risk groups generally were unable to show an effect of the intervention, which may reflect that most intervention effects were not sufficiently large to induce (...) significant overall change. Interventions targeting high-risk groups and conducted in school settings appeared to be slightly more effective than studies conducted in community settings. The authors’ state that “most of the previous studies that used high-risk strategies to identify susceptibility to future overweight and obesity, were selecting high risk individuals based on their ethnicity or socioeconomic status only, and more studies Which service or policy mechanisms, models or approaches, have been

2018 Public Health England - Evidence Briefings

162. Treadmill workstations in office workers who are overweight or obese: a randomised controlled trial. Full Text available with Trip Pro

Treadmill workstations in office workers who are overweight or obese: a randomised controlled trial. Treadmill workstations that enable office workers to walk on a treadmill while working at their computers might increase physical activity in offices, but long-term effects are unknown. We therefore investigated whether treadmill workstations in offices increased daily walking time.We did a randomised controlled trial of healthy office workers who were either overweight or obese. We recruited

2018 The Lancet. Public health Controlled trial quality: predicted high

163. Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study. (Abstract)

Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study. 30135268 2018 12 19 1024-2708 24 Suppl 4 4 2018 Aug Hong Kong medical journal = Xianggang yi xue za zhi Hong Kong Med J Lifestyle intervention in obese Chinese adolescents with non-alcoholic fatty liver disease: a randomised controlled study. 12-15 Chan D Fy DF Department of Paediatrics, The Chinese University of Hong Kong. Nelson E As EA Department of Paediatrics

2018 Hong Kong medical journal = Xianggang yi xue za zhi Controlled trial quality: uncertain

164. Obesity in Pregnancy

Obesity in Pregnancy No. 239-Obesity in Pregnancy - Journal of Obstetrics and Gynaecology Canada Email/Username: Password: Remember me Search Terms Search within Search Volume 40, Issue 8, Pages e630–e639 No. 239-Obesity in Pregnancy x Gregory A.L. Davies , MD Kingston, ON x Cynthia Maxwell , MD Toronto, ON x Lynne McLeod , MD Halifax, NS No. 239, February 2010 (Reaffirmed August 2018) DOI: To view the full text, please login as a subscribed user or . Click to view the full text (...) on ScienceDirect. Abstract Objective To review the evidence and provide recommendations for the counselling and management of obese parturients. Outcomes Outcomes evaluated include the impact of maternal obesity on the provision of antenatal and intrapartum care, maternal morbidity and mortality, and perinatal morbidity and mortality. Evidence Literature was retrieved through searches of Statistics Canada, Medline, and The Cochrane Library on the impact of obesity in pregnancy on antepartum and intrapartum

2018 Society of Obstetricians and Gynaecologists of Canada

165. Influence of subacute physical exercise on medium- and long-chain fatty acid profile in serum of individuals with overweight. Full Text available with Trip Pro

Influence of subacute physical exercise on medium- and long-chain fatty acid profile in serum of individuals with overweight. to test the hypothesis that acute physical exercise would change the fatty acids in the serum of individuals with increased body weight.sixty-six sedentary women with excess weight were included in the sample (BMI = 29.6 ± 4.2). They were aged 24.4 ± 3.6 years and were randomly divided into control and exercise groups. After 12 hours fasting, basal blood collection (...) ); azelaic (before = 20.3 ± 10.5% vs after = 27.7 ± 25.4%, p = 0.295); elaidic (before = 0.03 ± 0.01% vs after = 0.04 ± 0.01%, p = 0.328); oleic (before = 16.1 ± 7.4% vs after = 20.3 ± 14.6%, p = 0.236).pelargonic (before = 0.70 ± 0.45% vs after = 0.71 ± 0.51%, p = 0.776); azelaic (before = 62.1 ± 26% vs after = 57.1 ± 27%, p = 0.197); elaidic (before = 0.05 ± 0.02% mg/dl vs after = 0.05 ± 0.03%, p = 0.530); oleic (before = 26.8 ± 22.7% mg/dl vs after = 29.0 ± 22.4%, p = 0.525).in women with overweight

2018 Nutricion hospitalaria Controlled trial quality: uncertain

166. Obesity in children

. Centers for Disease Control and Prevention 2000 growth charts for the United States: improvements to the 1977 National Center for Health Statistics version. Pediatrics. 2002 Jan;109(1):45-60. http://www.ncbi.nlm.nih.gov/pubmed/11773541?tool=bestpractice.com Worldwide, the definition of overweight and obesity changes; however, a BMI >85th percentile is defined as overweight or at risk for overweight in the US and UK, a BMI ≥95th percentile is variably defined as obesity or overweight, and a BMI >99th (...) percentile is defined as severe obesity. Barlow SE. Expert Committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report. Pediatrics. 2007 Dec;120(suppl 4):S164-92. http://pediatrics.aappublications.org/content/120/Supplement_4/S164.full http://www.ncbi.nlm.nih.gov/pubmed/18055651?tool=bestpractice.com Canoy D, Bundred P. Obesity in children. BMJ Clin Evid. 2011 Apr 4;2011. pii: 0325. http://www.ncbi.nlm.nih.gov/pmc/articles

2018 BMJ Best Practice

167. Obesity in adults

guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines and The Obesity Society. Circulation. 2014 Jun 24;129(25 suppl 2):S102-38. http://circ.ahajournals.org/content/129/25_suppl_2/S102.long http://www.ncbi.nlm.nih.gov/pubmed/24222017?tool=bestpractice.com World Health Organization. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. Geneva, Switzerland (...) Obesity in adults Obesity in adults - Symptoms, diagnosis and treatment | BMJ Best Practice You'll need a subscription to access all of BMJ Best Practice Search  Obesity in adults Last reviewed: February 2019 Last updated: January 2018 Summary Presentation of obesity may range from asymptomatic to presentation complicated by multiple comorbidities, including cancer, CAD, diabetes, hypertension, gout, obstructive sleep apnoea, and osteoarthritis. The definitive test for the diagnosis of obesity

2018 BMJ Best Practice

168. Dose, Content, and Mediators of Family-Based Treatment for Childhood Obesity: A Multisite Randomized Clinical Trial Full Text available with Trip Pro

) with overweight and obesity (body mass index [BMI; calculated as weight in kilograms divided by height in meters squared] ≥85th percentile) with at least 1 parent with overweight and obesity (BMI ≥25) were recruited.HIGH SFM+ vs LOW SFM+ (CONTROL matched the dose of LOW).Intention-to-treat analysis using mixed-effects models estimated change in child percentage overweight (percentage above the median BMI for a child's age and sex) for the FBT period (0-4 months) and the SFM+ period (4-12 months (...) Dose, Content, and Mediators of Family-Based Treatment for Childhood Obesity: A Multisite Randomized Clinical Trial Elucidation of optimal dosing and treatment content is critical for health care providers, payers, and policy makers, as well as mechanisms of change to inform intervention delivery and training initiatives for childhood obesity.To evaluate effects, following a 4-month family-based behavioral weight loss treatment (FBT), of 2 doses (HIGH or LOW) of a weight-control intervention

2018 EvidenceUpdates

169. Clinic and Home-Based Behavioral Intervention for Obesity in Preschoolers: A Randomized Trial Full Text available with Trip Pro

Clinic and Home-Based Behavioral Intervention for Obesity in Preschoolers: A Randomized Trial To test the hypotheses that an innovative skills-based behavioral family clinic and home-based intervention (LAUNCH) would reduce body mass index z score (BMIz) compared with motivational interviewing and to standard care in preschool-aged children with obesity.Randomized controlled trial with children between the ages of 2 and 5 years above the 95th percentile for body mass index for age and sex

2018 EvidenceUpdates

171. Weight Loss to Prevent Obesity-Related Morbidity and Mortality in Adults: Behavioral Interventions

, behavior-based weight loss and weight loss maintenance interventions) has a moderate net benefit. Patient Population Under Consideration This recommendation applies to adults 18 years or older. The USPSTF uses the following terms to define categories of increased BMI: “overweight” is a BMI of 25 to 29.9 and “obesity” is a BMI of 30 or higher. Obesity can be categorized as class 1 (BMI of 30.0 to 34.9), class 2 (BMI of 35.0 to 39.9), or class 3 (BMI of ≥40) (see the for other USPSTF recommendations (...) Preventive Services Task Force recommends multicomponent interventions that use technology-supported coaching or counseling to help adults lose weight and maintain weight loss. Research Needs and Gaps Further research is needed to examine the effects of interventions for obesity on longer-term weight and health outcomes (eg, cardiovascular outcomes), including data on important subpopulations (eg, older adults, racial/ethnic groups, or persons who are overweight). Psychosocial, quality of life

2018 U.S. Preventive Services Task Force

172. Obesity Prevention and Control: Meal or Fruit and Vegetable Snack Interventions Combined with Physical Activity Interventions in Schools

these combined interventions increase students’ physical activity, modestly increase their fruit and vegetable consumption, and decrease the prevalence of overweight and obesity. There were not enough studies to determine whether these interventions work for middle and high school students. The CPSTF recommends the following related intervention approaches: Healthy Eating Interventions Alone Physical Activity Interventions The CPSTF finds insufficient evidence for two other intervention approaches that focus (...) in the . The systematic review included 21 studies with 22 study arms. Overweight and Obesity Prevalence The prevalence of overweight and obesity decreased by a median of 2.0 (7 studies). Physical Activity Physical activity increased by a median of 22 minutes per day (6 studies). Students’ cardiorespiratory fitness measures improved (8 studies). Fruit and Vegetable Consumption Students consumed 12 more fruits and vegetables per day (4 studies). The number of times per day students consumed fruits and vegetables

2018 Community Preventive Services Task Force

173. Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Full Text available with Trip Pro

Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Cluster randomised controlled trial and economic and process evaluation to determine the effectiveness and cost effectiveness of a novel intervention [Healthy Lifestyles Programme (HeLP)] to prevent obesity in school children Journals Library An error occurred retrieving (...) content to display, please try again. >> >> >> Page Not Found Page not found (404) Sorry - the page you requested could not be found. Please choose a page from the navigation or try a website search above to find the information you need. >> >> >> >> Issue {{metadata .Issue }} Toolkit 1)"> 0)"> 1)"> {{metadata.Title}} {{metadata.Headline}} The novel school-located Healthy Lifestyles Programme did not prevent obesity in 9-10 year olds at two year follow up. {{author}} {{($index

2018 NIHR HTA programme

174. Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease Full Text available with Trip Pro

Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease 29725628 2018 11 14 2468-0249 3 2 2018 Mar Kidney international reports Kidney Int Rep Time to Look Beyond Obesity Metrics and Mortality in Kidney Disease. 244-246 10.1016/j.ekir.2017.12.010 Navaneethan Sankar D SD Selzman Institute for Kidney Health, Section of Nephrology, Department of Medicine, Baylor College of Medicine, Houston, Texas, USA. Section of Nephrology, Michael E. DeBakey Veterans Affairs Medical Center, Houston (...) Am Soc Nephrol. 2018 Jan;29(1):250-259 29038285 Kidney Int. 2016 Mar;89(3):675-82 26880461 Obesity (Silver Spring). 2015 Apr;23(4):893-7 25755182 Ann Intern Med. 2006 Jan 3;144(1):21-8 16389251 Clin J Am Soc Nephrol. 2014 Dec 5;9(12):2079-88 25392147 Kidney Int. 2017 May;91(5):1224-1235 28187985 Kidney Int. 2018 Mar;93(3):733-740 29102374 BMC Nephrol. 2014 Jul 08;15:108 25005601 J Am Soc Nephrol. 2014 Sep;25(9):2088-96 24652789

2017 Kidney international reports

175. Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With CKD Full Text available with Trip Pro

Impact of Misclassification of Obesity by Body Mass Index on Mortality in Patients With CKD Unlike the general population, a higher body mass index (BMI) is associated with greater survival among patients with chronic kidney disease (CKD). This "obesity paradox" may be due to limitations of BMI as a measure of adiposity in CKD. Both BMI and body fat percentage (BF%) are used to classify obesity, but outcomes may vary. Therefore, we investigated the 2 different cutoffs for diagnosing obesity (...) -reactive protein.Per the BMI definition, 27.9% of patients were obese. However, 48.8% of patients were obese according to the BF% definition. A BMI ≥28 kg/m2 had a moderately high specificity of 83.2% but a low sensitivity of 39.6% for detecting BF%-defined obesity. In the fully adjusted models containing both BMI and BF%, obesity defined by BMI was associated with a significantly lower risk of death (hazard ratio [HR]: 0.23; 95% CI: 0.07-0.71; P = 0.011), whereas the result was reversed when obesity

2017 Kidney international reports

176. Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy Full Text available with Trip Pro

of ≥10% the baseline value at IGB removal and 12 maintained their weight below this threshold during the 6-12 following months.After temporary IGB implantation in overweight or obese individuals, a WL that was ≥10% of weight at baseline was achieved in 54.3% and sustained at 6-12 months in 41.4% of participants. IGBs are an attractive intermediate option between diet and exercise programs and bariatric surgery. In general, IGB placement is a safe and well-tolerated procedure. (...) Intragastric Balloon for Obesity Treatment: Safety, Tolerance, and Efficacy Obesity is an increasing worldwide problem associated with a vast number of comorbidities. Decreasing body weight by only 5-10% has been shown to slow and even prevent the onset of obesity-related comorbidities. Between pharmacological therapy and bariatric surgery a great variety of endoscopic techniques are available, the most common being intragastric balloon (IGB). The purpose of this study was to assess the safety

2017 GE Portuguese journal of gastroenterology

177. Walkable neighborhoods and obesity: Evaluating effects with a propensity score approach Full Text available with Trip Pro

Walkable neighborhoods and obesity: Evaluating effects with a propensity score approach Research investigating the connection between neighborhood walkability and obesity often overlooks the issue of nonrandom residential selection.We use propensity score methods to adjust for the nonrandom selection into residential neighborhoods in this cross-sectional, observational study. The sample includes 103,912 women residing in Salt Lake County, Utah age 20 or older. We measured percentage living (...) in neighborhoods with more walkability, area level measures of neighborhood characteristics, and obesity (body mass index (BMI) > 30).Our findings confirm previous work that observes an association between living in more walkable neighborhoods and lower obesity. After adjusting for nonrandom selection, the odds of being obese when living in a less walkable neighborhood increase. Specifically, the odds ratio for being obese without the propensity score correction is 1.12. After adjusting for nonrandom selection

2017 SSM - population health

178. Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension) Full Text available with Trip Pro

Effects of Bariatric Surgery in Obese Patients With Hypertension: The GATEWAY Randomized Trial (Gastric Bypass to Treat Obese Patients With Steady Hypertension) Recent research efforts on bariatric surgery have focused on metabolic and diabetes mellitus resolution. Randomized trials designed to assess the impact of bariatric surgery in patients with obesity and hypertension are needed.In this randomized, single-center, nonblinded trial, we included patients with hypertension (using ≥2 (...) . Waist circumference, body mass index, fasting plasma glucose, glycohemoglobin, low-density lipoprotein cholesterol, triglycerides, high-sensitivity C-reactive protein, and 10-year Framingham risk score were lower in the gastric bypass than in the control group.Bariatric surgery represents an effective strategy for blood pressure control in a broad population of patients with obesity and hypertension.URL: https://clinicaltrials.gov. Unique identifier: NCT01784848.© 2017 The Authors.

2017 EvidenceUpdates

179. Naltrexone?bupropion for managing overweight and obesity

Naltrexone?bupropion for managing overweight and obesity Naltre Naltrex xone–bupropion for managing one–bupropion for managing o ov verweight and obesity erweight and obesity T echnology appraisal guidance Published: 12 December 2017 nice.org.uk/guidance/ta494 © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and-conditions#notice-of- rights).Y Y our responsibility our responsibility The recommendations in this guidance represent the view of NICE (...) . Commissioners and providers have a responsibility to promote an environmentally sustainable health and care system and should assess and reduce the environmental impact of implementing NICE recommendations wherever possible. Naltrexone–bupropion for managing overweight and obesity (TA494) © NICE 2018. All rights reserved. Subject to Notice of rights (https://www.nice.org.uk/terms-and- conditions#notice-of-rights). Page 2 of 17Contents Contents 1 Recommendations 4 2 The technology 5 3 Committee discussion 6

2017 National Institute for Health and Clinical Excellence - Technology Appraisals

180. A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial Full Text available with Trip Pro

A Medically Supervised Pregnancy Exercise Intervention in Obese Women: A Randomized Controlled Trial To evaluate whether an intensive, medically supervised exercise intervention improved maternal glycemia and gestational weight gain in obese pregnant women when compared with routine prenatal care.This randomized controlled trial compared a medically supervised exercise intervention with routine prenatal care. The primary outcome was a reduction in mean maternal fasting plasma glucose (...) of gestation, excessive gestational weight gain greater than 9.1 kg was lower in the exercise group, 23.5% compared with 45.2% in the control group (P<.05).An intensive, medically supervised exercise intervention for obese women from early pregnancy did not improve maternal glycemia. Pregnant women who are obese, however, should be advised to exercise because it attenuates excessive gestational weight gain.International Standard Randomised Controlled Trials (ISRCTN) registry, ISRCTN 31045925.

2017 EvidenceUpdates